Applera Board Okays Applied Biosystems Stock Buyback | GenomeWeb

NEW YORK, Aug. 29 (GenomeWeb News) – Applied Biosystems said today that its repurchase of up to $200 million of its common stock has been approved by the board of directors of its parent firm, Applera.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.